- Home
- ACHV vs ATLO Comparison
ACHV vs ATLO Comparison
Compare ACHV & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- ATLO
- Stock Information
- Founded
- ACHV N/A
- ATLO 1903
- Country
- ACHV Canada
- ATLO United States
- Employees
- ACHV N/A
- ATLO N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ATLO Major Banks
- Sector
- ACHV Health Care
- ATLO Finance
- Exchange
- ACHV Nasdaq
- ATLO Nasdaq
- Market Cap
- ACHV 126.9M
- ATLO 144.8M
- IPO Year
- ACHV N/A
- ATLO N/A
- Fundamental
- Price
- ACHV $2.85
- ATLO $17.69
- Analyst Decision
- ACHV Strong Buy
- ATLO
- Analyst Count
- ACHV 5
- ATLO 0
- Target Price
- ACHV $14.80
- ATLO N/A
- AVG Volume (30 Days)
- ACHV 283.6K
- ATLO 27.7K
- Earning Date
- ACHV 11-07-2024
- ATLO 01-28-2025
- Dividend Yield
- ACHV N/A
- ATLO 5.70%
- EPS Growth
- ACHV N/A
- ATLO N/A
- EPS
- ACHV N/A
- ATLO 0.98
- Revenue
- ACHV N/A
- ATLO $51,071,000.00
- Revenue This Year
- ACHV N/A
- ATLO N/A
- Revenue Next Year
- ACHV N/A
- ATLO N/A
- P/E Ratio
- ACHV N/A
- ATLO $17.71
- Revenue Growth
- ACHV N/A
- ATLO N/A
- 52 Week Low
- ACHV $2.87
- ATLO $15.69
- 52 Week High
- ACHV $5.59
- ATLO $22.41
- Technical
- Relative Strength Index (RSI)
- ACHV 25.46
- ATLO 62.10
- Support Level
- ACHV $3.12
- ATLO $16.95
- Resistance Level
- ACHV $3.86
- ATLO $17.93
- Average True Range (ATR)
- ACHV 0.22
- ATLO 0.43
- MACD
- ACHV -0.04
- ATLO 0.17
- Stochastic Oscillator
- ACHV 0.98
- ATLO 87.30
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About ATLO Ames National Corporation
Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.